The Neuropathology Core is essential to establish definitive postmortem diagnosis for prospectively enrolled clinical patients, genetic family members, sibpairs and controls. Brains are sectioned and examined according to established protocols. Senile plaques are estimated according to CERAD; neurofibrillary changed staged according to Braak and Braak and NIA-Reagan Instituted criteria applied for diagnosis. Dementia with Lewy bodies is evaluated according to Consensus criteria and Vascular dementia classified according to NINDS-AIREN guidelines. To properly evaluate new diagnostic and treatment modalities and to validate genetic studies, postmortem examination is required to diagnosis and stage AD, evaluate coexisting pathology and to establish other causes of dementia. Although there have been rapid advances in recent years in development of animal models of AD, none fully mimic human disease. Specifically, none exhibit neurofibrillary change which some investigators view as the most significant pathology. Dementia with Lewly bodies account for 20% of dementia cases examined by this Core, but no models exist for Lewy body pathology. Also, there is no adequate model of Vascular dementia. Began in 1985, the Bryan Autopsy Program has changed significantly as the research needs of the Bryan ADRC have evolved. Nevertheless, the Bryan ADRC Autopsy Program remains successful in procuring human tissue as quickly as possible after death. In recent years, a major goal of the Neuropathology Core have been recruited of normal controls. Since 1992, normal controls have been followed with annual neuropsychologic testing and are now coming to autopsy in increasing numbers. The Bryan ADRC Brain Bank is currently a repository of 803 fixed and frozen human brain specimens with detailed neuropathologic examinations and is capable of supplying human tissue to internal investigators as well as to investigators from institutions across the US and worldwide. The Brain Bank serves as a routing service for tissue and data through the Clinical Core and the research projects.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005128-19S1
Application #
6616267
Study Section
Project Start
2002-08-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
19
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Ghani, Mahdi; Reitz, Christiane; Cheng, Rong et al. (2015) Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol 72:1313-23

Showing the most recent 10 out of 97 publications